Home
 /
Papers
 /
Genomics
 /
Whole-genome 3D architectural screen reveals modulators of brain DNA structure
Preprint
Open access
V1
Top 1% · Validated by QED

Whole-genome 3D architectural screen reveals modulators of brain DNA structure

Bibudha Parasar, Achuthan Raja Venkatesh, Jonathan Perera +13 more
April 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.04.15.718501
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genomics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Plate-C scales whole-genome 3D profiling to thousands of conditions per day, conducting the first chemical screen of chromatin architecture and establishing that metabolic, immune, and neurotransmission pathways are direct genome-rewiring signals, validated in living brains.

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

The 3D structure of the genome is not static — it can be rapidly and specifically rewired within hours by manipulating common biochemical pathways (HDAC, mTOR, Wnt, immune signaling, and others). These structural changes are dose-, time-, cell type-, and species-dependent, meaning genome architecture responds to perturbations with remarkable specificity. This suggests the 3D genome is a druggable, dynamically programmable system, opening the door to deliberately engineering genome structure for therapeutic purposes.

”
Longzhi Tan

QED claims analysis

Summary

A high-throughput platform for profiling whole-genome 3D architecture across thousands of conditions reveals that diverse epigenetic, metabolic, proteostatic, developmental, immune, and neurotransmission pathways rapidly remodel neuronal and glial genome organization in dose-, time-, cell-type-, and species-dependent modes that are highly conserved between in vitro and in vivo systems, with chemically induced structural changes driving widespread transcriptional programs orthogonal to normal differentiation.

See full analysis
Main Claim 1 –

Plate-C Enables Genome-Wide 3D Screening at Near-1000 Conditions

Main Claim 2 –

Diverse Pathway-Targeting Compounds Rewire Genome Architecture in Brain Cells

Supporting evidence

  • Compounds Cluster into Convergent and Divergent Genome-Rewiring Modes
  • Genome Architectural Responses Show Dose Dependence and Drug Interactions
  • Chemical Genome Rewiring Exhibits Temporal Dynamics and 24-Hour Plateau
  • Genome Architecture Rewires Within One Hour of Chemical Perturbation
  • Genome Architectural Responses Are Cell-Type and Species Specific
Main Claim 3 –

Human Neurons Remodel Genome Architecture to Metabolic and Stress Signals

Supporting evidence

  • Single-Cell Validation Reveals Differentiation-Dependent Genome Rewiring in Neurons
Main Claim 4 –

In Vitro Structural Hits Predict In Vivo Genome Rewiring

Supporting evidence

  • In Vivo Genome Rewiring Precedes Cell-Type Specific Transcriptional Changes

Abstract

Three-dimensional (3D) genome architecture is the foundation of gene regulation, and plays a critical role in normal physiology and disease. However, our understanding of its biochemical determinants has long been limited by technology: imaging-based screens only profile a small number of loci, while sequencing-based studies rarely exceed 100 samples or conditions. Here we present “in-plate chromosome conformation capture” (Plate-C), a high-throughput, cost-effective platform that profiles thousands of whole-genome architectures in a day. Plate-C enabled the first chemical screen for whole-genome structural changes—profiling 2,956 samples from 834 conditions across 5 neuronal and glial types, accompanied by 6,081 single cells using “easy diploid chromosome conformation capture” (Easy Dip-C) and 200,893 single-cell transcriptomes. We discovered that diverse, dose/time-dependent, and cell type/species-specific modes of DNA structural changes can be rapidly induced by manipulating epigenetic (HDAC, BET), metabolic (mTOR), proteostatic (UPR), developmental (GSK3/Wnt, Hedgehog), immune (cGAS/STING), and neurotransmission pathways. To validate our finding in vivo, we demonstrated in newborn mice that HDAC inhibition drives brain-wide genome rewiring within hours, highly correlated with changes in vitro and inducing a latent structural and transcriptional state orthogonal to normal differentiation. By enabling massively parallel profiling of whole-genome structures, Plate-C paves the way for systematic discovery of DNA folding principles to better understand and engineer the human genome in 3D.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?